As per the report, the joint pain injections market size was US$ 4.16 billion in 2021. It is projected to grow US$ 7.59 billion by 2030 at a CAGR of 6.9% in the forecast period.
Any of the ligaments, bursae, or tendons that surround the joint can be injured, causing joint discomfort. Joint pain injections are medications that are injected directly into the joints to assist reduce inflammation and discomfort in the patient. Inflammatory joint disorders such as psoriatic arthritis, rheumatoid arthritis, bursitis, osteoarthritis, gout, and other types of joint pain are commonly treated with joint pain injections, also known as intra-articular injections.
Download the FREE Sample Report (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1449
Market Overview
A recent study by Precedence Research on the joint pain injections market offers a forecast for 2021 and 2030. The study analyzes crucial trends that are currently determining the growth of the joint pain injections market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of joint pain injections. The study also provides the dynamics that are responsible for influencing the future status of this market over the forecast period.
A detailed assessment of the joint pain injections market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the joint pain injections market along with their product portfolio enhances the reliability of this comprehensive research study.
Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market
Key Points
- Primary Research
- Secondary Research
- Market Size Estimation
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Challenges
- Macroeconomic Indicators
- Technology Trends and Assessment
- Market Factor Analysis
- Porter’s Five Forces Analysis
- Bargaining Power Of Suppliers
- Bargaining Power Of Buyers
- Threat Of New Entrants
- Threat Of Substitutes
- Intensity Of Rivalry
- Value Chain Analysis
- Investment Feasibility Analysis
- Pricing Analysis
Research Methodology
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, the structure of the market participants and industry's competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
Industry participants involved in this research study include:
- CEOs, VPs, market intelligence managers
- Procuring and national sales managers technical personnel, distributors and resellers
- Research analysts and key opinion leaders from various domains
Competition Landscape
In the final section of the report on the global joint pain injections market, a 'dashboard view' of the companies has been provided to compare the current market scenario and the contribution of companies to the global joint pain injections market. Moreover, the report is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to segments of the global market. Report audiences can gain segment-specific manufacturer insights to identify and evaluate key competitors based on an in-depth assessment of their capabilities and success in the joint pain injections marketplace.
Some of the prominent players in the global joint pain injections market include:
- Anika Therapeutics Inc.
- Bioventus
- Ferring Pharmaceuticals Inc.
- Sanofi
- Zimmer Biomet Holdings Inc.
- Allergen Plc.
- Pfizer Inc.
- Chugai Pharmaceutical Co. Ltd
- SEIKAGAKU Corporation
- Ferring B.V.
Market Segmentation
Segments of the global joint pain injections market have been analyzed in terms of their market share to understand an individual segment’s relative contribution to market growth. This detailed level of information is important for identifying key trends in the global joint pain injections market.
Market Segments as below:
By Injection Type
- Corticosteroid Injections
- Hyaluronic Acid Injections
- Platelet-rich Plasma Injections
- Placental tissue matrix (PTM) Injections
By Joint Type
- Knee and Ankle
- Hip
- Shoulder and Elbow
- Spinal Joints
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Product Type
- Pre-filled injections
- Vials
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Joint Pain Injections Market
5.1. COVID-19 Landscape: Joint Pain Injections Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Joint Pain Injections Market, By Product
8.1. Joint Pain Injections Market, by Product Type, 2021-2030
8.1.1. Pre-filled injections
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Vials
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Joint Pain Injections Market, By Injection
9.1. Joint Pain Injections Market, by Injection, 2021-2030
9.1.1. Corticosteroid Injections
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Hyaluronic Acid Injections
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Platelet-rich Plasma Injections
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Placental tissue matrix (PTM) Injections
9.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Joint Pain Injections Market, By Joint Type
10.1. Joint Pain Injections Market, by Joint Type, 2021-2030
10.1.1. Knee and Ankle
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Hip
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Shoulder and Elbow
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Spinal Joints
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Joint Pain Injections Market, By Distribution Type
11.1. Joint Pain Injections Market, by Distribution Type, 2021-2030
11.1.1. Hospital Pharmacies
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Retail Pharmacies
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. Online Pharmacies
11.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Joint Pain Injections Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.2. Market Revenue and Forecast, by Injection (2019-2030)
12.1.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.1.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.5.2. Market Revenue and Forecast, by Injection (2019-2030)
12.1.5.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.1.5.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.6.2. Market Revenue and Forecast, by Injection (2019-2030)
12.1.6.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.1.6.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.2. Market Revenue and Forecast, by Injection (2019-2030)
12.2.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.2.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.5.2. Market Revenue and Forecast, by Injection (2019-2030)
12.2.5.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.2.5.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.6.2. Market Revenue and Forecast, by Injection (2019-2030)
12.2.6.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.2.6.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.7.2. Market Revenue and Forecast, by Injection (2019-2030)
12.2.7.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.2.7.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.8.2. Market Revenue and Forecast, by Injection (2019-2030)
12.2.8.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.2.8.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.2. Market Revenue and Forecast, by Injection (2019-2030)
12.3.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.3.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.5.2. Market Revenue and Forecast, by Injection (2019-2030)
12.3.5.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.3.5.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.6.2. Market Revenue and Forecast, by Injection (2019-2030)
12.3.6.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.3.6.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.7.2. Market Revenue and Forecast, by Injection (2019-2030)
12.3.7.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.3.7.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.8.2. Market Revenue and Forecast, by Injection (2019-2030)
12.3.8.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.3.8.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.2. Market Revenue and Forecast, by Injection (2019-2030)
12.4.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.4.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.5.2. Market Revenue and Forecast, by Injection (2019-2030)
12.4.5.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.4.5.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.6.2. Market Revenue and Forecast, by Injection (2019-2030)
12.4.6.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.4.6.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.7.2. Market Revenue and Forecast, by Injection (2019-2030)
12.4.7.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.4.7.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.8.2. Market Revenue and Forecast, by Injection (2019-2030)
12.4.8.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.4.8.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.2. Market Revenue and Forecast, by Injection (2019-2030)
12.5.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.5.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.5.2. Market Revenue and Forecast, by Injection (2019-2030)
12.5.5.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.5.5.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.6.2. Market Revenue and Forecast, by Injection (2019-2030)
12.5.6.3. Market Revenue and Forecast, by Joint Type (2019-2030)
12.5.6.4. Market Revenue and Forecast, by Distribution Type (2019-2030)
Chapter 13. Company Profiles
13.1. Online Pharmacies
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bioventus
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Ferring Pharmaceuticals Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Sanofi
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Zimmer Biomet Holdings Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Allergen Plc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Pfizer Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Chugai Pharmaceutical Co. Ltd
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. SEIKAGAKU Corporation
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Ferring B.V.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Why Buy this Report?
The purpose of Precedence Research's joint pain injections market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1449
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments